Skip to main content

Table 4 Comparisons between 195 T1DM patients with low and 83 T1DM patients with high levels of sTWEAK

From: Low levels of soluble TWEAK, indicating on-going inflammation, were associated with depression in type 1 diabetes: a cross-sectional study

 

sTWEAK

 

Low levels (< 7.2 ng/ml)

High levels (≥7.2 ng/ml)

P - value a

N

195

83

 

Age (years)

42 (32, 51)

42 (29, 51)

0.79

Diabetes duration (years)

20 (11, 30)

18 (9, 29)

0.58

Sex

 Women

89 (46)

30 (36)

0.15 b

 Men

106 (54)

53 (64)

Depression

27 (14)

2 (2)

0.003 b

High galectin-3 (≥2.6 ng/ml) c

27 (14)

14 (17)

0.58 b

High HbA1c (> 70 mmol/mol (> 8.6%))

53 (27)

22 (26)

> 0.99 b

Total cholesterol (mmol/l)

4.6 (4.1, 5.2)

4.5 (4.0, 5.0)

0.13

LDL (mmol/l)

2.9 (2.4, 3.4)

2.8 (2.4, 3.2)

0.34

Triglycerides (mmol/l)

0.9 (0.7, 1.3)

0.8 (0.7, 1.2)

0.19

HDL (mmol/l)

1.5 (1.3, 1.8)

1.6 (1.3, 1.8)

0.71

Triglycerides/HDL-cholesterol ratio

0.6 (0.4–0.9)

0.6 (0.4–0.8)

0.23

S-Creatinine (μmol/l) d

70 (62, 77)

70 (62, 80)

0.44

Abdominal obesity e

33 (17)

11 (13)

0.48 b

BMI (kg/m2) f

24.6 (22.4, 27.9)

24.6 (23.1, 26.1)

0.92

Systolic BP (mm Hg)

120 (110, 130)

120 (110, 130)

0.34

Diastolic BP (mm Hg)

70 (70, 75)

70 (65, 78)

0.54

Hypoglycemia (severe episodes)

7 (4)

4 (5)

0.74 b

Smoking g

20 (11)

8 (10)

> 0.99 b

Physical inactivity h

24 (13)

5 (6)

0.19 b

Continuous subcutaneous insulin infusion

11 (6)

14 (17)

0.005 b

Antidepressants

16 (8)

6 (7)

> 0.99 b

Lipid lowering drugs

92 (47)

36 (43)

0.60 b

Antihypertensive drugs

62 (32)

26 (31)

> 0.99 b

Cardiovascular complications

8 (4)

2 (2)

0.73 b

  1. N = 278. Data are presented as median (q1, q3) or N (%). a Mann-Whitney U test unless otherwise indicated
  2. b Fisher’s Exact Test. Missing values: c 4; d 12; e 6; f 2; g, h 16